Objective: To investigate how dexamethasone dosage impacts intratympanic steroid therapy (IST) for treatment of sudden sensorineural hearing loss (SSNHL).
Study Design: Retrospective review.
Methods: Inclusion criteria identified subjects who received IST between January 1, 2010 and June 1, 2020 for iSSNHL.